Medicine & Life Sciences
4-methyl-N-(3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-pyridin-3-ylpyrimidin-2-yl)amino)benzamide
15%
Acetylation
21%
Acute Myeloid Leukemia
100%
Apoptosis
98%
Azacitidine
14%
B-Cell Lymphoma
15%
bcr-abl Fusion Proteins
15%
Blast Crisis
12%
Bone Marrow Cells
18%
Breast Neoplasms
20%
Caspase 3
14%
Catenins
13%
Cell Line
13%
Cytarabine
72%
Cytochromes c
20%
Dasatinib
13%
Deoxycytidine
33%
DNA Fragmentation
18%
Epigenomics
12%
epothilone B
17%
geldanamycin
15%
Growth
19%
Histone Deacetylase Inhibitors
80%
HL-60 Cells
58%
HSP90 Heat-Shock Proteins
42%
Imatinib Mesylate
51%
In Vitro Techniques
16%
K562 Cells
13%
LAQ824
34%
Leukemia
66%
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
40%
Lymphoma, Large B-Cell, Diffuse
13%
Mantle-Cell Lymphoma
18%
Mutation
24%
Myeloid Cells
43%
Myeloid Leukemia
23%
Myeloid Progenitor Cells
23%
Neoplasms
32%
Paclitaxel
51%
Panobinostat
67%
Protein-Tyrosine Kinases
21%
Proteins
29%
Stem Cells
18%
Survival
23%
tanespimycin
20%
Therapeutics
22%
venetoclax
20%
Vorinostat
29%
Chemistry
Acetylation
5%
Agar
5%
Androgen
5%
Antagonist
5%
Antiapoptotic
6%
Antileukemic Agent
8%
Antitumor
5%
Apoptotic
10%
Cell Death
10%
Colony Stimulating Factor
9%
Cytarabine
6%
Cytochrome
5%
dCTP
6%
Dose
5%
Fragmentation
6%
Heat
9%
Histone
20%
Hsp90 Inhibitor
10%
Hydroxamic Acid
6%
Imatinib
19%
Lethal
7%
Mutation
16%
Nilotinib
7%
Phosphatidylinositol
5%
Protein
21%
Reactive Oxygen Metabolite
5%
Resistance
12%
Tyrosine
5%
Tyrosine Kinase Inhibitor
11%
Venetoclax
8%